LBel

Product NDC
14783-446
11-digit product format
147830446
Labeler code
14783
Product ID
14783-446_ca71761d-0b6d-491d-ae64-7f234b1d4428
Type
HUMAN OTC DRUG
Nonproprietary name
TITANIUM DIOXIDE, OXYBENZONE, and OCTINOXATE
Dosage form
POWDER
Route
TOPICAL
Labeler
Ventura International Ltd
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2012-01-24
Marketing end
0000-00-00
Substance
TITANIUM DIOXIDE; OXYBENZONE; OCTINOXATE
Active strength
0 g/g; g/g; g/g
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct14783-446DDiscontinued by firm2026-10-15
excluded packagepackage14783-44614783-446-02DDiscontinued by firm2026-10-15
excluded packagepackage14783-44614783-446-04DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage14783-446-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage14783-446-04DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage14783-446-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage14783-446-04DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage14783-446-02DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage14783-446-04DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage14783-446-02DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage14783-446-04DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage14783-446-02DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage14783-446-04DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage14783-446-04IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage14783-446-02IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage14783-446-04IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage14783-446-02IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage14783-446-04IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage14783-446-02IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage14783-446-04IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage14783-446-02IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage14783-446-04IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage14783-446-02IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage14783-446-04IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage14783-446-02IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage14783-446-04IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage14783-446-02IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproductIInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage14783-446-04IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage14783-446-02IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproductIInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage14783-446-04IInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage14783-446-02IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproductIInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage14783-446-04IInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage14783-446-02IInactivated by FDA1332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage14783-446-04IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage14783-446-02IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage14783-446-04IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage14783-446-02IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage14783-446-04IInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage14783-446-02IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage14783-446-04IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage14783-446-02IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage14783-446-04IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage14783-446-02IInactivated by FDAe2bbac7714bc…27bdfed8d636…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
14783-446-022025-03-11L'BEL EFFET PARFAIT
14783-446-042025-03-11L'BEL EFFET PARFAIT
14783-446-022019-11-13L'BEL EFFET PARFAIT
14783-446-042019-11-13L'BEL EFFET PARFAIT

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD51LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
OXYBENZONEACTIVE INGREDIENT95OOS7VE0YLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JPLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
OCTINOXATEACTIVE MOIETY4Y5P7MUD51LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
OXYBENZONEACTIVE MOIETY95OOS7VE0YLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JPLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
BORON NITRIDEINACTIVE INGREDIENT2U4T60A6YDLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
CERAMIDE 3INACTIVE INGREDIENT4370DF050BLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
GLYCERYL CAPRYLATEINACTIVE INGREDIENTTM2TZD4G4ALBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
IMPERATA CYLINDRICA ROOTINACTIVE INGREDIENTVYT2JA85NHLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
ISONONYL ISONONANOATEINACTIVE INGREDIENTS4V5BS6GCXLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
KAOLININACTIVE INGREDIENT24H4NWX5COLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
LAUROYL LYSINEINACTIVE INGREDIENT113171Q70BLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
MICAINACTIVE INGREDIENTV8A1AW0880LBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHLBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1
TALCINACTIVE INGREDIENT7SEV7J4R1ULBEL EFFET PARFAIT (TITANIUM DIOXIDE, OXYBENZONE, AND OCTINOXATE) POWDER [VENTURA INTERNATIONAL LTD]1